Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

MENT: summary of concept data and preclinical and clinical results

Feb. 9, 1998

Antiobesity and antidiabetic compounds claimed by American Home Products

Feb. 6, 1998

Boehringer Mannheim develops new agents for diabetes

Feb. 6, 1998

Zestril introduced for new indication in U.K.

Feb. 5, 1998

NexMed completes phase I trial of ED product

Feb. 4, 1998

Androtab-SL NDA is inadequate for approval, FDA says

Feb. 3, 1998

EPO peptides and anti-EPO antibodies from Behringwerke

Feb. 3, 1998

Somatostatin receptor ligands synthesized by Novo Nordisk

Feb. 2, 1998

Schering-Plough to copromote Novo Nordisk's Prandin

Jan. 30, 1998

Oxytocin antagonist licensed by Tokyo Tanabe enters clinic

Jan. 30, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...